Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma

María Monteagudo(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Luis J. Leandro‐García(Spanish National Cancer Research Centre), María Currás-Freixes(Spanish National Cancer Research Centre), Hanna Remde(University of Würzburg), Giovanna Roncador(Spanish National Cancer Research Centre), Eduardo Gil(Spanish National Centre for Cardiovascular Research), Felix Beuschlein(University of Zurich), Martin Faßnacht(University of Würzburg), Marta Pulgarín-Alfaro(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Massimo Mannelli(University of Florence), Sara Mellid(Spanish National Cancer Research Centre), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Sonsoles Guadalix(Research Institute Hospital 12 de Octubre), Nicole Bechmann(University Hospital Carl Gustav Carus), Bruna Calsina(Spanish National Cancer Research Centre), Raúl Torres(Spanish National Cancer Research Centre), Rita María Regojo(Hospital Universitario La Paz), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Letizia Canu(Azienda Ospedaliero-Universitaria Careggi), Diego Megı́as(Spanish National Cancer Research Centre), Scherezade Jiménez-Villa(Spanish National Cancer Research Centre), Manuel Pérez‐Martínez(Spanish National Cancer Research Centre), Paula Martínez(Spanish National Cancer Research Centre), Sandra Rodríguez(Spanish National Cancer Research Centre), Alberto Díaz‐Talavera(Centro de Biología Molecular Severo Ochoa), Svenja Nölting(University of Zurich), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Marcus Quinkler(Charité - Universitätsmedizin Berlin), María Calatayud(Hospital Universitario 12 De Octubre), Alberto Cascón(Spanish National Cancer Research Centre), Marı́a A. Blasco(Spanish National Cancer Research Centre), Elena Rapizzi(El.En. Group (Italy)), Patricia González(Neuron BioPharma (Spain)), Rocío Letón, Ángel M. Martínez‐Montes(Spanish National Cancer Research Centre), Eduardo Caleiras(Spanish National Cancer Research Centre)
Cancers
September 23, 2021
Cited by 24


Related Papers